Table 5 Region-specific positive biopsies, stratified by the number of biopsy sessions

From: Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting

Region

Number of biopsy sessions

 

1 n %

2 n (%)

3 n (%)

4+ n (%)

All n (%)

Base

          

 1

15

19.0%

23

15.8%

11

13.1%

9

14.1%

58

15.5%

 2

16

20.3%

19

13.0%

7

8.3%

5

7.8%

47

12.6%

 3

13

16.5%

8

5.5%

4

4.8%

3

4.7%

28

7.5%

 4

11

13.9%

4

2.7%

2

2.4%

1

1.6%

18

4.8%

 5

17

21.5%

19

13.0%

7

8.3%

4

6.3%

47

12.6%

 6

20

25.3%

17

11.6%

7

8.3%

5

7.8%

49

13.1%

 7

10

12.7%

18

12.3%

9

10.7%

8

12.5%

45

12.1%

 8

17

21.5%

21

14.4%

10

11.9%

7

10.9%

55

14.7%

Midgland

          

 9

20

25.3%

22

15.1%

10

11.9%

8

12.5%

60

16.1%

 10

17

21.5%

20

13.7%

4

4.8%

6

9.4%

47

12.6%

 11

22

27.8%

19

13.0%

6

7.1%

4

6.3%

51

13.7%

 12

17

21.5%

14

9.6%

8

9.5%

4

6.3%

43

11.5%

 13

17

21.5%

13

8.9%

5

6.0%

2

3.1%

37

9.9%

 14

18

22.8%

18

12.3%

4

4.8%

3

4.7%

43

11.5%

 15

13

16.5%

18

12.3%

5

6.0%

5

7.8%

41

11.0%

 16

14

17.7%

23

15.8%

9

10.7%

5

7.8%

51

13.7%

 17

14

17.7%

18

12.3%

12

14.3%

8

12.5%

52

13.9%

 18

15

17.7%

26

17.8%

8

9.5%

8

12.5%

56

15.0%

Apex

          

 19

28

35.4%

34

23.3%

16

19.0%

11

17.2%

89

23.9%

 20

23

29.1%

21

14.4%

7

8.3%

4

6.3%

55

14.7%

 21

20

25.3%

16

11.0%

7

8.3%

5

7.8%

48

12.9%

 22

14

17.7%

14

9.6%

6

7.1%

5

7.8%

39

10.5%

 23

14

17.7%

26

17.8%

11

13.1%

3

4.7%

54

14.5%

 24

22

27.8%

37

25.3%

20

23.8%

8

12.5%

87

23.3%